Brand Name: Genius" Review Station Product Name: Genius" Review Station Display (Barco Monitor) ...
FDA Device Recall #Z-1949-2026 — Class II — March 23, 2026
Recall Summary
| Recall Number | Z-1949-2026 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 23, 2026 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Hologic, Inc |
| Location | Marlborough, MA |
| Product Type | Devices |
| Quantity | 1200 units |
Product Description
Brand Name: Genius" Review Station Product Name: Genius" Review Station Display (Barco Monitor) Model/Catalog Number: CMP-01669 Software Version: N/A - not software version specific Component: Yes, the Genius" Review Station is a component of the Genius" Digital Diagnostics System with the Genius" Cervical AI Algorithm cleared under DEN210035.
Reason for Recall
It was identified that certain devices were being operated outside the validated and FDA-cleared display configuration due to user modification of the manufacturer-installed settings. Modifications included disabling Barco Application Appearance Manager (AAM), altering calibration and compliance parameters, and adjusting additional display-related settings. This field correction is being conducted to restore affected system to the validated configuration and reinforce proper use in accordance with the Operator's Manual.
Distribution Pattern
Worldwide distribution - US Nationwide and the countries of Asia Pacific, Europe, and the Middle East.
Lot / Code Information
Model Number: CMP-01669; UDI-DI: 15420045514201; Serial Number: All;
Other Recalls from Hologic, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2168-2026 | Class II | 3DIMENSIONS MAMMOGRAPHY SYSTEM; Model Numbers: ... | Apr 8, 2026 |
| Z-2167-2026 | Class II | SELENIA DIMENSIONS MAMMOGRAPHY SYSTEMS. Model N... | Apr 8, 2026 |
| Z-1314-2026 | Class II | Brevera Breast Biopsy System Disposable 9 Gauge... | Dec 15, 2025 |
| Z-1093-2026 | Class II | ThinPrep¿ CytoLyt¿ Solution. Buffered Cell Wash... | Dec 12, 2025 |
| Z-1170-2025 | Class II | Brand Name: Sertera Biopsy Device Product Name... | Jan 15, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.